| Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study T Marzo, D Cirri, C Gabbiani, T Gamberi, F Magherini, A Pratesi, A Guerri, ... ACS Medicinal Chemistry Letters 8 (10), 997-1001, 2017 | 110 | 2017 |
| Insights on the mechanism of thioredoxin reductase inhibition by gold N-heterocyclic carbene compounds using the synthetic linear selenocysteine containing C-terminal peptide … A Pratesi, C Gabbiani, E Michelucci, M Ginanneschi, AM Papini, ... Journal of Inorganic Biochemistry 136, 161-169, 2014 | 102 | 2014 |
| Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs D Cirri, A Pratesi, T Marzo, L Messori Expert opinion on drug discovery 16 (1), 39-46, 2021 | 76 | 2021 |
| Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis A Pratesi, C Gabbiani, M Ginanneschi, L Messori Chemical communications 46 (37), 7001-7003, 2010 | 76 | 2010 |
| Replacement of the thiosugar of auranofin with iodide enhances the anticancer potency in a mouse model of ovarian cancer T Marzo, L Massai, A Pratesi, M Stefanini, D Cirri, F Magherini, M Becatti, ... ACS Medicinal Chemistry Letters 10 (4), 656-660, 2019 | 71 | 2019 |
| ESI MS studies highlight the selective interaction of Auranofin with protein free thiols C Zoppi, L Messori, A Pratesi Dalton Transactions 49 (18), 5906-5913, 2020 | 67 | 2020 |
| Antiproliferative effects of two gold (I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study F Magherini, T Fiaschi, E Valocchia, M Becatti, A Pratesi, T Marzo, ... Oncotarget 9 (46), 28042, 2018 | 58 | 2018 |
| Selection and characterization of a human ovarian cancer cell line resistant to auranofin I Landini, A Lapucci, A Pratesi, L Massai, C Napoli, G Perrone, P Pinzani, ... Oncotarget 8 (56), 96062, 2017 | 55 | 2017 |
| Strategies for the improvement of metal-based chemotherapeutic treatments D Cirri, F Bartoli, A Pratesi, E Baglini, E Barresi, T Marzo Biomedicines 9 (5), 504, 2021 | 51 | 2021 |
| Reactions of auranofin and its pseudohalide derivatives with serum albumin investigated through ESI-Q-TOF MS A Pratesi, D Cirri, L Ciofi, L Messori Inorganic Chemistry 57 (17), 10507-10510, 2018 | 50 | 2018 |
| Reactions of medicinal gold (III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods L Massai, C Zoppi, D Cirri, A Pratesi, L Messori Frontiers in Chemistry 8, 581648, 2020 | 49 | 2020 |
| A fluorescent silver (I) carbene complex with anticancer properties: synthesis, characterization, and biological studies MG Fabbrini, D Cirri, A Pratesi, L Ciofi, T Marzo, A Guerri, S Nistri, ... ChemMedChem 14 (1), 182-188, 2019 | 45 | 2019 |
| Ruthenium arene complexes with triphenylphosphane ligands: cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution L Biancalana, A Pratesi, F Chiellini, S Zacchini, T Funaioli, C Gabbiani, ... New Journal of Chemistry 41 (23), 14574-14588, 2017 | 45 | 2017 |
| Structural characterization of a gold/serum albumin complex A Pratesi, D Cirri, D Fregona, G Ferraro, A Giorgio, A Merlino, L Messori Inorganic Chemistry 58 (16), 10616-10619, 2019 | 43 | 2019 |
| A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes F Guarra, A Pratesi, C Gabbiani, T Biver Journal of Inorganic Biochemistry 217, 111355, 2021 | 41 | 2021 |
| The cisplatin/serum albumin system: A reappraisal L Massai, A Pratesi, J Gailer, T Marzo, L Messori Inorganica Chimica Acta 495, 118983, 2019 | 38 | 2019 |
| Photocytotoxic Pt (iv) complexes as prospective anticancer agents G Canil, S Braccini, T Marzo, L Marchetti, A Pratesi, T Biver, T Funaioli, ... Dalton Transactions 48 (29), 10933-10944, 2019 | 35 | 2019 |
| Doing care, doing citizenship: Towards a micro-situated and emotion-based model of social inclusion A Pratesi Springer, 2017 | 35 | 2017 |
| Two mixed valence diruthenium (II, III) isomeric complexes show different anticancer properties E Barresi, I Tolbatov, T Marzo, E Zappelli, A Marrone, N Re, A Pratesi, ... Dalton Transactions 50 (27), 9643-9647, 2021 | 34 | 2021 |
| Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study I Tolbatov, D Cirri, L Marchetti, A Marrone, C Coletti, N Re, D La Mendola, ... Frontiers in Chemistry 8, 812, 2020 | 34 | 2020 |